(RVMD) Revolution Medicines - Performance -5% in 12m
RVMD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
1.60%
#34 in Peer-Group
Rel. Strength
33.54%
#4936 in Stock-Universe
Total Return 12m
-4.95%
#65 in Peer-Group
Total Return 5y
25.22%
#26 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 60.60 USD |
| 52 Week Low | 31.13 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 10.46 |
| Buy/Sell Signal +-5 | -0.56 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RVMD (-5%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: RVMD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RVMD
| Total Return (including Dividends) | RVMD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -9.25% | 2.27% | 4.52% |
| 3 Months | 9.73% | 6.30% | 10.43% |
| 12 Months | -4.95% | -10.68% | 14.67% |
| 5 Years | 25.22% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | RVMD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -80.4% | 5.5% | 79.1% |
| 3 Months | 48.7% | 74.3% | 94.2% |
| 12 Months | -63.9% | -84.7% | 44.4% |
| 5 Years | 25% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th27.50 | -11.27% | -13.17% |
| 3 Month | %th54.00 | 3.22% | -0.64% |
| 12 Month | %th67.50 | 6.41% | -17.11% |
| 5 Years | %th87.00 | 69.52% | -40.15% |
FAQs
Does Revolution Medicines (RVMD) outperform the market?
Yes,
over the last 12 months RVMD made -4.95%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months RVMD made 9.73%, while XBI made 6.30%.
Performance Comparison RVMD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RVMD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9.6% | -13.8% | -22.4% | -20% |
| US NASDAQ 100 | QQQ | -9.2% | -13.9% | -23.7% | -19% |
| German DAX 40 | DAX | -7.9% | -8.2% | -33.9% | -34% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -8.7% | -13.4% | -23.4% | -23% |
| Hongkong Hang Seng | HSI | -7.9% | -15.3% | -40.2% | -41% |
| India NIFTY 50 | INDA | -9.7% | -11.6% | -20.7% | -5% |
| Brasil Bovespa | EWZ | -10.7% | -16.8% | -45.3% | -18% |
RVMD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -10.2% | -15.3% | -27.5% | -33% |
| Consumer Discretionary | XLY | -9.1% | -11.3% | -15.2% | -25% |
| Consumer Staples | XLP | -8.6% | -8.8% | -22% | -15% |
| Energy | XLE | -8.5% | -13.6% | -16.4% | -2% |
| Financial | XLF | -9.9% | -12.9% | -26.2% | -35% |
| Health Care | XLV | -10% | -12.8% | -16.4% | -1% |
| Industrial | XLI | -9.9% | -13.3% | -29.6% | -30% |
| Materials | XLB | -10.6% | -13.5% | -25.5% | -11% |
| Real Estate | XLRE | -6.5% | -9.9% | -21.3% | -18% |
| Technology | XLK | -9.4% | -17.2% | -24.7% | -16% |
| Utilities | XLU | -8.3% | -9.7% | -25.1% | -30% |
| Aerospace & Defense | XAR | -10.3% | -16.5% | -40.9% | -54% |
| Biotech | XBI | -7% | -11.5% | -6.9% | 6% |
| Homebuilder | XHB | -12.2% | -19.7% | -15.9% | -10% |
| Retail | XRT | -10.6% | -13.7% | -16.7% | -14% |
RVMD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -9.1% | -15.6% | -12.3% | 4% |
| Natural Gas | UNG | -0.8% | 1.2% | -5% | 4% |
| Gold | GLD | -8.3% | -7.9% | -41.5% | -48% |
| Silver | SLV | -8.2% | -12.9% | -37.7% | -27% |
| Copper | CPER | -10.7% | -13.2% | -40.8% | -20% |
RVMD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -8.7% | -12.8% | -18.6% | -7% |
| iShares High Yield Corp. Bond | HYG | -7.8% | -10.5% | -20.3% | -15% |